|
|
|
|
| LEADER |
01649nam a2200325 u 4500 |
| 001 |
EB002001128 |
| 003 |
EBX01000000000000001164029 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 100 |
1 |
|
|a Banerjee, Srabani
|
| 245 |
0 |
0 |
|a Natriuretic peptide testing for monitoring of heart failure therapy
|h Elektronische Ressource
|b a review of clinical effectiveness, clinical utility, cost-effectiveness, and guidelines
|c Srabani Banerjee, Suzanne McCormack
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa (ON)
|b CADTH
|c 2019, August 19, 2019
|
| 300 |
|
|
|a 1 PDF file (29 pages)
|b illustration
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Natriuretic Peptides / blood
|
| 653 |
|
|
|a Prognosis
|
| 653 |
|
|
|a Cost-Benefit Analysis
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Guidelines as Topic
|
| 653 |
|
|
|a Heart Failure / drug therapy
|
| 700 |
1 |
|
|a McCormack, Suzanne
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK549365
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 700
|
| 520 |
|
|
|a The purpose of this report is to review the clinical effectiveness, clinical utility, and cost effectiveness of natriuretic peptide testing for monitoring of heart failure therapy. Additionally, this report aims to review the evidence-based guidelines regarding natriuretic peptide testing for monitoring of heart failure therapy
|